scholarly journals Gastrointestinal perforation: relation to corticosteroid use and COPD – a case report

2016 ◽  
Vol 6 (4) ◽  
pp. 32129
Author(s):  
Michael H.K. Nguyen ◽  
Krista M. Isaac ◽  
Rebecca Dougherty
2021 ◽  
pp. 1-3
Author(s):  
Victor Dominguez Prieto ◽  
Victor Dominguez Prieto ◽  
Cecilia Meliga ◽  
Sara Rosenstone ◽  
Siyuan Qian Zhang ◽  
...  

Tocilizumab is a monoclonal antibody against the interleukin-6 receptor. Gastrointestinal perforation has been associated with Tocilizumab treatment. In the absence of specific antiviral drugs, Tocilizumab is currently being used as a treatment option in patients with severe COVID-19 pneumonia. This is being based on the implication of interleukin-6 in the aberrant host immune response that characterizes the disease and initiates patients' lung damage. Herein we present the case of a cecal perforation in a patient treated with Tocilizumab for COVID-19. In such context, we expect that there may be an increase in the incidence of gastrointestinal perforation related to Tocilizumab.


2021 ◽  
Author(s):  
Yuri Shimada ◽  
Yuki Sato ◽  
Ryo Tachikawa ◽  
Shigeo Hara ◽  
Keisuke Tomii

Abstract Gastrointestinal perforation related to mitogen-activated protein kinase kinase (MEK) inhibitors has been reported previously; however, there has been no case report of such a condition in patients with non-small cell lung cancer (NSCLC). Herein, we report a case of small intestinal perforation secondary to dabrafenib and trametinib administration, but not related to tumor regression. A 62-year-old man with non-small cell lung cancer harboring BRAF V600E mutation was treated with dabrafenib and trametinib. Four months after the initiation of treatment, a small intestinal perforation was diagnosed. Dabrafenib and trametinib rechallenge was performed after gastrointestinal perforation. The patient responded well to therapy and did not experience recurrence of gastrointestinal perforation. To the best of our knowledge, this is the first report of gastrointestinal perforation in a patient with NSCLC treated with a MEK inhibitor. The mechanism and risk factors of trametinib-induced perforation are currently unknown. Physicians should be aware of such severe gastrointestinal side effects of trametinib.


2018 ◽  
Vol 4 (4) ◽  
Author(s):  
Hanzhang Dong ◽  
Xuhui Chen ◽  
Yanfei Jiang ◽  
YHao Chen ◽  
Mingyi Wu ◽  
...  

PEDIATRICS ◽  
1951 ◽  
Vol 7 (3) ◽  
pp. 415-421
Author(s):  
CHARLES D. COOK ◽  
JOHN R. HARTMANN ◽  
STANLEY J. SARNOFF ◽  
WILLIAM BERENBERG

Five patients with severe bulbar poliomyelitis complicated by gastrointestinal perforation and/or hemorrhage are presented. A detailed case report is given in the one patient who recovered. The electrophrenic respirator was instrumental in maintaining this patient's respiration and massive blood transfusions in preventing shock from intestinal hemorrhage. The gastrointestinal complications of bulbar poliomyelitis appear to be more frequent than previously realized. A relationship between midbrain damage and gastrointestinal lesions, as emphasized by Cushing, occurring during the course of acute bulbar poliomyelitis, is postulated.


2017 ◽  
Vol 40 (5) ◽  
pp. 382-386 ◽  
Author(s):  
Takao KIBOSHI ◽  
Kentaro ISODA ◽  
Koichi FURUKAWA ◽  
Tomoyuki WAKAHARA ◽  
Kenichiro OTANI ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document